Angelova-Toshkina Daniela, Decker Josua A, Traunwieser Thomas, Holzapfel Johannes, Bette Stefanie, Huber Simon, Schimmel Mareike, Vollert Kurt, Bison Brigitte, Kröncke Thomas, Bramswig Nuria C, Wieczorek Dagmar, Gnekow Astrid K, Frühwald Michael C, Kuhlen Michaela
Paediatric and Adolescent Medicine, University Medical Centre, Stenglinstr. 2, 86156, Augsburg, Germany.
Department of Diagnostic and Interventional Radiology and Neuroradiology, University Medical Centre, Stenglinstraße 2, 86156, Augsburg, Germany.
Eur J Paediatr Neurol. 2023 Mar;43:52-61. doi: 10.1016/j.ejpn.2023.02.006. Epub 2023 Mar 5.
Neurofibromatosis type 1 (NF1) is a phenotypically heterogenous multisystem cancer predisposition syndrome manifesting in childhood and adolescents. Central nervous system (CNS) manifestations include structural, neurodevelopmental, and neoplastic disease. We aimed to (1) characterize the spectrum of CNS manifestations of NF1 in a paediatric population, (2) explore radiological features in the CNS by image analyses, and (3) correlate genotype with phenotypic expression for those with a genetic diagnosis. We performed a database search in the hospital information system covering the period between January 2017 and December 2020. We evaluated the phenotype by retrospective chart review and imaging analysis. 59 patients were diagnosed with NF1 [median age 10.6 years (range, 1.1-22.6); 31 female] at last follow-up, pathogenic NF1 variants were identified in 26/29. 49/59 patients presented with neurological manifestations including 28 with structural and neurodevelopmental findings, 16 with neurodevelopmental, and 5 with structural findings only. Focal areas of signal intensity (FASI) were identified in 29/39, cerebrovascular anomalies in 4/39. Neurodevelopmental delay was reported in 27/59 patients, learning difficulties in 19/59. Optic pathway gliomas (OPG) were diagnosed in 18/59 patients, 13/59 had low-grade gliomas outside the visual pathways. 12 patients received chemotherapy. Beside the established NF1 microdeletion, neither genotype nor FASI were associated with the neurological phenotype. NF1 was associated with a spectrum of CNS manifestations in at least 83.0% of patients. Regular neuropsychological assessment complementing frequent clinical and ophthalmologic testing for OPG is necessary in the care of each child with NF1.
